Serum ferritin as a clinical marker for renal cell carcinoma: Influence of tumor size and volume

Urologia Internationalis

Volumn 62, Issue 1, 1999, Pages 21-25

  Kirkali, Ziya ^a   Güzelsoy, Muhammet ^a   Ugur Mungan M ^a   Kirkali, Güldal ^a   Yörükoǧlu, Kutsal ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Ferritin; Kidney tumor; Renal cell carcinoma; Tumor marker

Indexed keywords

FERRITIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; ENZYME IMMUNOASSAY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; KIDNEY CARCINOMA; KIDNEY VEIN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VEIN; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; FERRITINS; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0344604456     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030349     Document Type: Article

References (16)

1. DeKernion JB, Belldegrun A: Renal tumors; in Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr (eds): Campbell's Urology, ed 6. Philadelphia, Saunders, 1992, pp 1053-1093.
2. Richards B, Robinson MR, Pidcock NB, Cooper EH: Serum ferritin profiles in carcinoma of the kidney. Eur Urol 1982;8:32.
3. Echique JE, Graham SD Jr: Significance of lipid-associated sialic acid and 19-9 as tumor markers for renal cell carcinoma. Urology 1988;32:397.
4. Chu TM, Shukla SK, Mittleman AO, Murphy GP: Plasma carcinoembryonic antigen in renal cell carcinoma patients. J Urol 1942;11:742.
5. Babaian RT, Swanson DA: Serum haptoglobulin: A non-specific tumor marker for renal cell carcinoma. South Med J 1982;75:1345.
6. Sufrin G, Mink I, Fitzpatric J, Moore R, Murphy GP: Coagulation factors in renal adenocarcinoma. J Urol 1978;119:727.
7. Nseyo VO, Williams PD, Murphy GP: Clinical significance of erythropoietin levels in renal carcinoma. Urology 1986;28:301.
8. Kirkali Z, Esen A, Kirkali G, Güner G: Ferritin: A tumor marker expressed by renal cell carcinoma. Eur Urol 1995;28:131.
9. Özen H, Uygur C, Şahin A, Tekgül S, Ergen A, Remzi D: Clinical significance of serum ferritin in patients with renal cell carcinoma. Urology 1995;46:494.
10. Partin AW, Criley SR, Steiner MS, Hsieh K, Simons JW, Lumadue J, Carter HB, Marshall FF: Serum ferrtin as a clinical marker for renal cell carcinoma: Influence of tumor volume. Urology 1995;45:211.
11. Union International Contre le Cancer: The TNM Classification of Tumors 1992. Geneva, UICC, 1992.
12. Jacobs A, Path FR, Worwood M: Ferritin in serum clinical and biochemical implications. N Engl J Med 1975;292:951.
13. Güner G, Kirkali G, Yenisey C, Töre İR: Cytosol and serum ferritin in breast carcinoma. Cancer Lett 1992;67:103.
14. Esumi N, Ikusshima S, Sigeyhashi H, Shingora J, Imashuku S: High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome. Cancer 1987;61:2071.
15. Mason DY, Taylor CR: Distribution of transferrin, ferritin and lactoferrin in human tissue. J Clin Pathol 1978;31:316.
16. Mufti GJ, Humblin TJ, Stevens J: Basic isoferritin and hypercalcemia in renal cell carcinoma. J Clin Pathol 1982;35:1008.